EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ten-Year Survival Rate of 82% in 262 Cases of Arthroscopic Bone Marrow Stimulation for Osteochondral Lesions of the Talus

Quinten G H Rikken iD, Margot B Aalders, Jari Dahmen iD, Inger N Sierevelt iD, Sjoerd A S Stufkens iD, Gino M M J Kerkhoffs iD

Journal of Bone and Joint Surgery · 2024

DOI: 10.2106/jbjs.23.01186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bone and Joint Surgery, 2024. Verfasst von Quinten G H Rikken und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery and Sports Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Talus, Arthroscopy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The long-term sustainability of arthroscopic bone marrow stimulation (BMS) for osteochondral lesions of the talus (OLT) remains a matter of debate. The primary aim of the present study was to assess the 10-year survival free from revision in ankles that had undergone arthroscopic BMS for an OLT. The secondary aim was to evaluate the influence of baseline patient and lesion characteristics on survival.

Methods

Patients who underwent arthroscopic BMS for a symptomatic OLT and had a minimum follow-up of 10 years were included to assess procedure survival. The primary outcome, the 10-year cumulative survival rate, was analyzed by the Kaplan-Meier survival method. Secondary outcomes were the median time to revision and the effects of baseline factors (lesion size, primary or non-primary lesion type, preoperative cysts, and obesity as defined by a body mass index [BMI] of ≥30 kg/m 2 ) on survival, analyzed with a Cox regression model and reported using hazard ratios (HRs).

Results

The 262 included patients had a mean follow-up of 15.3 ± 4.8 years. The 10-year cumulative survival rate of the arthroscopic BMS procedures was 82% (95% confidence interval [CI]: 77% to 87%). At 15 years of follow-up, the cumulative survival rate was 82% (95% CI: 76% to 86%). The median time to revision was 2.4 years (interquartile range: 1.3 to 5.1 years). Of the baseline factors, obesity (HR: 3.0 [95% CI: 1.44 to 6.43], p < 0.01) was associated with decreased survival. Lesion size (HR: 0.9 [95% CI: 0.5 to 1.8], p = 0.8), non-primary lesion type (HR: 1.8 [95% CI: 0.9 to 3.4], p = 0.1), and the presence of preoperative cysts (HR: 1.0 [95% CI: 0.6 to 1.9], p = 0.9) were not significantly associated with survival.

Conclusions

At a minimum follow-up of 10 years, the survival rate of arthroscopic BMS for OLT was 82%. At 15 and 20 years of follow-up, survival appeared to remain stable. Obesity (BMI ≥ 30 kg/m 2 ) was associated with a higher likelihood of revision surgery. This risk factor should be incorporated into the treatment algorithm for OLT when counseling patients regarding surgery. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TalusArthroscopyHumansMaleFemaleAdultMiddle AgedReoperationBone MarrowRetrospective StudiesFollow-Up StudiesTreatment OutcomeCartilage, Articular

Autor:innen und Institutionen

  • Department of Orthopedic Surgery and Sports Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Sports and Musculoskeletal Health Programs, Amsterdam Movement Sciences, Amsterdam, The Netherlands.
  • Academic Center for Evidence-based Sports Medicine (ACES), Amsterdam UMC, Amsterdam, The Netherlands.
  • Amsterdam Collaboration for Health and Safety in Sports (ACHSS), International Olympic Committee (IOC) Research Centre, Amsterdam UMC, Amsterdam, The Netherlands.
  • Orthopedic Department, Spaarne Gasthuis Academy, Hoofddorp, The Netherlands.

ORCID-Profile: Quinten G H Rikken, Jari Dahmen, Inger N Sierevelt, Sjoerd A S Stufkens, Gino M M J Kerkhoffs

Zitieren

APA

Rikken, Q. G. H., Aalders, M. B., Dahmen, J., Sierevelt, I. N., Stufkens, S. A. S., & Kerkhoffs, G. M. M. J. (2024). Ten-Year Survival Rate of 82% in 262 Cases of Arthroscopic Bone Marrow Stimulation for Osteochondral Lesions of the Talus. Journal of Bone and Joint Surgery. https://doi.org/10.2106/jbjs.23.01186

Vancouver

Rikken QGH, Aalders MB, Dahmen J, Sierevelt IN, Stufkens SAS, Kerkhoffs GMMJ. Ten-Year Survival Rate of 82% in 262 Cases of Arthroscopic Bone Marrow Stimulation for Osteochondral Lesions of the Talus. Journal of Bone and Joint Surgery. 2024. doi:10.2106/jbjs.23.01186

BibTeX
@article{Rikken2024,
  author = {Rikken, Quinten G H and Aalders, Margot B and Dahmen, Jari and Sierevelt, Inger N and Stufkens, Sjoerd A S and Kerkhoffs, Gino M M J},
  title = {Ten-Year Survival Rate of 82% in 262 Cases of Arthroscopic Bone Marrow Stimulation for Osteochondral Lesions of the Talus},
  journal = {Journal of Bone and Joint Surgery},
  year = {2024},
  doi = {10.2106/jbjs.23.01186}
}
Kostenlos starten →